Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Mawson Infrastructure Group Inc. Director's Dealing 2017

Nov 27, 2017

35202_dirs_2017-11-27_60eb2c50-6e18-42c0-91e2-60529585eba6.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Wize Pharma, Inc. (WIZP)
CIK: 0001218683
Period of Report: 2017-11-16

Reporting Person: Ridge Valley Corp (10% Owner)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock, par value $0.001 per share 19853641 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
2017 Convertible Notes $0.50 2017-12-31 Common Stock, par value $0.001 per share (6075903) Direct
Future Investment Rights $0.60 2017-06-30 Common Stock, par value $0.001 per share (7401034) Direct